Publication Type : Journal Article
Thematic Areas : Biotech
Publisher : Bioorganic and Medicinal Chemistry Letters
Source : Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 19, pp. 4735-4742, 2014.
Url : http://www.scopus.com/inward/record.url?eid=2-s2.0-84906576374&partnerID=40&md5=15b4b7336b6c327a952d6b0b4c51a67a
Campus : Amritapuri
School : School of Biotechnology
Center : Biotechnology, Phytochemistry Labs
Department : biotechnology
Year : 2014
Abstract : pSeventeen flavonoids with different substitutions were evaluated for inhibition of nuclear factor-κB (NF-κB) signaling in the invasive breast cancer cell line MDA-MB-231. They were screened using an engineered MDA-MB-231 cell line reporting NF-κB activation. The modulation of expression of two NF-κB regulated genes involved in tumorigenesis, matrix metalloproteinase-9 (MMP-9), and cyclooxygenase-2 (COX-2) were also analyzed in these cells. Among the compounds tested, all except gossypetin and quercetagetin inhibited the activation of NF-κB, and the expression of MMP-9 and COX-2 to different degree. Methylated flavone, chrysoeriol (luteolin-3′-methylether), was found to be the most potent inhibitor of MMP-9 and COX-2 expressions. The effect of chrysoeriol on cell proliferation, cell cycle, apoptosis and metastasis was analyzed by established methods. Chrysoeriol caused cell cycle arrest at G2/M and inhibited migration and invasion of MDA-MB-231 cells. The structure-activity relations amongst the flavonoids as NF-κB signaling inhibitors was studied. The study indicates differences between the actions of various flavonoids on NF-κB activation and on the biological activities of breast cancer cells. Flavones in general, were more active than the corresponding flavonols. © 2014 Elsevier Ltd. All rights reserved./p
Cite this Research Publication : Ka Amrutha, Pandurangan Nanjan, Shaji, S. Ka, Sunilkumar, Da, Subhalakshmi, Ka, Rajakrishna, Lb, and Dr. Asoke Banerji, “Discovery of lesser known flavones as inhibitors of NF-κB signaling in MDA-MB-231 breast cancer cells-A SAR study”, Bioorganic and Medicinal Chemistry Letters, vol. 24, no. 19, pp. 4735-4742, 2014.